Litigation Details for Walgreen Co. v. Gilead Sciences, Inc. (N.D. Cal. 2021)
✉ Email this page to a colleague
Walgreen Co. v. Gilead Sciences, Inc. (N.D. Cal. 2021)
Docket | ⤷ Try a Trial | Date Filed | 2021-09-22 |
Court | District Court, N.D. California | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | Edward Milton Chen |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,043,230; 6,639,071; 6,642,245; 6,703,396; 8,592,397; 8,716,264; 9,457,036 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Walgreen Co. v. Gilead Sciences, Inc.
Biologic Drugs cited in Walgreen Co. v. Gilead Sciences, Inc.
Details for Walgreen Co. v. Gilead Sciences, Inc. (N.D. Cal. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-09-22 | 1 | Complaint | 5,977,089 (“the ‘089 Patent”), and 6,043,230 (“the ‘230 Patent”). These three 11 patents all derive from the… the TDF Patents (the 9 ‘695 patent, the ‘089 patent, the ‘230 patent, and the ‘946 patent), which …Gilead’s Viread patent portfolio consists of U.S. Patents Nos. 5,922,695 (“the 10 ‘695 Patent”), 5,977,089… (“the ‘245 patent”) and 6,703,396 (“the ‘396 patent”) 8 (collectively “the FTC Patents”). Truvada … invalid. 18 These patents include U.S. Patent Nos. 8,592,397 (“the ‘397 patent”), 8,716,264 (“the ‘ | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |